- Home
- MRNA vs SQM Comparison
MRNA vs SQM Comparison
Compare MRNA & SQM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | SQM |
|---|---|---|
| Founded | 2010 | 1968 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6B | 24.0B |
| IPO Year | 2018 | 1997 |
Fundamental Metrics
Financial Performance| Metric | MRNA | SQM |
|---|---|---|
| Price | $63.32 | $79.22 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 10 |
| Target Price | $34.27 | ★ $68.80 |
| AVG Volume (30 Days) | ★ 6.0M | 1.2M |
| Earning Date | 05-01-2026 | 05-26-2026 |
| Dividend Yield | N/A | ★ 0.74% |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,263,000,000.00 | N/A |
| Revenue This Year | $9.36 | N/A |
| Revenue Next Year | $15.43 | $7.83 |
| P/E Ratio | ★ N/A | $39.64 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.28 | $34.44 |
| 52 Week High | $67.74 | $98.00 |
Technical Indicators
Market Signals| Indicator | MRNA | SQM |
|---|---|---|
| Relative Strength Index (RSI) | 75.16 | 46.11 |
| Support Level | $45.69 | $78.01 |
| Resistance Level | N/A | $81.67 |
| Average True Range (ATR) | 3.88 | 3.13 |
| MACD | 1.81 | 0.60 |
| Stochastic Oscillator | 85.43 | 56.53 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About SQM Sociedad Quimica y Minera S.A.
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM also sells lithium concentrate from a joint venture hard rock lithium project in Australia and expanding its lithium refining assets in China.